Viewing nowGlucophage 250mg (Metformin Hydrochloride)
Metformin Hydrochloride 250mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

MFDS item code 200401014 · Notified 2004.03.03 · Insurance code 644501340
Treatment of type 2 diabetes mellitus
This medication is mainly used for the treatment of patients with type 2 diabetes whose blood sugar is not adequately controlled by diet and exercise alone, particularly in overweight adult patients. In adults, this medication can be used alone or in combination with other oral hypoglycemic agents or insulin. It can also be used as monotherapy or in combination with insulin in children aged 10 and older and adolescents. This medication effectively improves blood sugar control, assisting in the management of diabetes.
The dose should be determined individually based on drug response and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate blood glucose control, treatment with this medicine must be initiated at a low dose: administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 administrations daily with meals; the maximum daily dose is 2550mg. At the start of treatment and when adjusting the dose, fasting blood glucose should be measured to assess the therapeutic response to this medicine and identify the minimum effective dose. Blood glycosylated hemoglobin levels should be measured approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose had been controlled with diet therapy alone, short-term treatment with this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment: This medicine may be used, with the following dose adjustments, in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine must be discontinued immediately.
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.
This medication can cause severe lactic acidosis or hypoglycemia, so caution is required during use. It should not be administered to patients with moderate to severe renal impairment, those who are dehydrated or have serious infections, cardiovascular collapse, acute myocardial infarction, sepsis, or other acute conditions that can affect renal function. It is also contraindicated in patients with acute or unstable heart failure, those scheduled to receive iodinated contrast agents, those with allergies to this medication or similar medications, type 1 diabetes patients, and patients with diabetic ketoacidosis. Patients with severe infections or severe traumatic systemic disorders should temporarily discontinue drug therapy and can resume it once their condition improves. Administration should be stopped 48 hours prior to surgery and treatment should be resumed after renal function has been confirmed to be normal. Caution is required when this medication is administered to patients with malnutrition, starvation, frailty, liver dysfunction, pneumonitis, or severe respiratory dysfunction. Gastrointestinal side effects can commonly occur with this medication; starting with a meal or gradually increasing the dosage may help reduce side effects. Lactic acidosis, while rare, is a serious side effect; symptoms such as fatigue, myalgia, dyspnea, or abdominal pain should be reported to medical personnel immediately. Since this medication is primarily excreted through the kidneys, renal function should be regularly monitored and dosage adjustments or discontinuation may be necessary in cases of decreased renal function. Alcohol intake should be avoided as it may increase the risk of side effects from this medication. When used in combination with other medications that can affect blood sugar control, careful monitoring of blood sugar levels is necessary, especially when used with insulin or sulfonylureas as the risk of hypoglycemia may increase. During pregnancy, as this medication can cross the placenta, its use should be discussed with a physician if necessary, and caution is also required during breastfeeding due to unknown effects on newborns. Elderly patients commonly have decreased renal function, thus dosage should be carefully adjusted and renal function should be regularly monitored. In the case of overdose, emergency treatment is needed as the drug can be removed via hemodialysis. This medication does not cause weight gain, which may help with weight management; however, caution is needed when used in children or adolescents. Finally, keep this medication out of reach of children and avoid transferring it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is prone to influence from air or moisture, so it must be stored in a tightly closed container. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius. Proper storage ensures the medication's effectiveness is preserved.
White, round, film-coated tablet imprinted with the letter 'M' on one side and the number '250' on the other side.
90 tablets (15 tablets/PTPX6), 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 250mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.